New pill shows promise for weight loss in clinical trial
Disease control
Completed
This study tested whether a new oral medication called TERN-601 helps adults with overweight or obesity lose weight. Researchers compared the drug to a placebo (inactive pill) in 167 participants over 12 weeks. The main goal was to see how much body weight changed and to check th…
Phase: PHASE2 • Sponsor: Terns, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC